Shukra Pharmaceuticals P/E Ratio
Shukra Pharmaceuticals (SHUKRAPHAR) P/E ratio is 50.51 (High), EPS (TTM) ₹0.22, current price ₹32.44 on BSE vs historical average P/E of 89.77 — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Shukra Pharmaceuticals stock price NSE .
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
SHUKRAPHAR P/E Ratio — Valuation Signal & Historical Context
Shukra Pharmaceuticals P/E 50.51 vs historical average 89.77, range 89.77–89.77 — signal: Overvalued. Analyse SHUKRAPHAR promoter holding to track promoter, FII and institutional holdings.
- Stock appears overvalued with PE of 50.51, suggesting caution for new investments
- Current PE is 43.7% below historical average
Shukra Pharmaceuticals P/E Ratio Historical Trend
SHUKRAPHAR annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 50.51 vs historical average 89.77. View Shukra Pharmaceuticals yearly highs lows for the annual high/low range and current price position.
SHUKRAPHAR Historical P/E Ratio — EPS, Year-End Price & Valuation
Shukra Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on BSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 89.77 | 0.66 | ₹59.25 | BSE | High |
SHUKRAPHAR vs Healthcare Peers — P/E Ratio Comparison
Shukra Pharmaceuticals P/E 50.51 vs Healthcare average 48.94, median 26.94 — range 1.17–869.57.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.17 | ₹43 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.93 | ₹1,136 | Low |
| Amwill Health Care | AMWILL | 5.67 | ₹64 | Low |
| Medicamen Organics | MEDIORG | 6.4 | ₹27 | Low |
| Zenith Drugs | ZENITHDRUG | 6.83 | ₹69 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.99 | ₹2,364 | Low |
| Galaxy Medicare | GML | 8.78 | ₹31 | Low |
| Brooks Laboratories | BROOKS | 9.86 | ₹211 | Low |
| Accretion Pharmaceuticals | ACCPL | 10.92 | ₹78 | Low |